What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?
Authors
Keywords
-
Journal
LIVER TRANSPLANTATION
Volume 17, Issue S2, Pages S26-S33
Publisher
Wiley
Online
2011-06-08
DOI
10.1002/lt.22352
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems
- (2010) C. CAMMÀ et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Selecting an optimal staging system for hepatocellular carcinoma
- (2010) Chia-Yang Hsu et al. CANCER
- A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system
- (2010) Chia-Yang Hsu et al. JOURNAL OF HEPATOLOGY
- Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
- (2010) Alejandro Forner et al. SEMINARS IN LIVER DISEASE
- A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma
- (2009) Giuseppe Cabibbo et al. HEPATOLOGY
- Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis
- (2009) Gisèle N'Kontchou et al. HEPATOLOGY
- Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
- (2009) Andrew X. Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Staging systems: is there a surgical staging and a medical one?
- (2009) Ryota Masuzaki et al. Journal of Hepato-Biliary-Pancreatic Sciences
- 1057 PLASMA BIOMARKERS AS PREDICTORS OF OUTCOME IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: RESULTS FROM THE RANDOMIZED PHASE III SHARP TRIAL
- (2009) J. Llovet et al. JOURNAL OF HEPATOLOGY
- Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria
- (2009) Francesco D'Amico et al. LIVER TRANSPLANTATION
- Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States
- (2009) Elizabeth A. Pomfret et al. LIVER TRANSPLANTATION
- Liver Transplantation for Hepatocellular Carcinoma: Beyond the Milan Criteria
- (2008) F. Y. Yao AMERICAN JOURNAL OF TRANSPLANTATION
- Liver Transplantation for Hepatocellular Carcinoma Under Calcineurin Inhibitors
- (2008) Marco Vivarelli et al. ANNALS OF SURGERY
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
- (2008) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Validation of a New Prognostic Staging System for Hepatocellular Carcinoma: A Comparison of the Biomarker-Combined Japan Integrated Staging Score, the Conventional Japan Integrated Staging Score and the BALAD Score
- (2008) Satoshi Kitai et al. ONCOLOGY
- Liver Transplantation for Hepatocellular Carcinoma Without Preoperative Tumor Biopsy
- (2008) Philippe Compagnon et al. TRANSPLANTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now